| Ytd | -18.62% | |
| 1y | -41.84% |
| Open | 12.66 | Prev Close | 13.00 | Low | 12.26 | High | 12.86 | Mkt Cap | 826.69M |
| Vol | 1.59M | Avg Vol | 2.51M | EPS | 1.95 | P/E | 6.34 | Forward P/E | 6.09 |
| Beta | 0.83 | Short Ratio | 3.58 | Inst. Own | 101.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 9.64 | 200-d Avg | 10.11 | 1yr Est | 23.81 |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
On August 12, 2026, Rapid7 Inc (RPD) shares fell 8.2% to a current price of $12.27. This decline com
BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Rapid7 (NASDAQ: RPD), a global leader in AI-powered manage
DA Davidson analyst Rudy Kessinger maintains Rapid7 (NASDAQ:RPD) with a Underperform and raises t
Gainers Quantum (NASDAQ:QMCO) stock rose 56.7% to $18.45 during Tuesday's regular session. The
RBC Capital analyst Matthew Hedberg maintains Rapid7 (NASDAQ:RPD) with a Sector Perform and raise
Scotiabank analyst Patrick Colville maintains Rapid7 (NASDAQ:RPD) with a Sector Perform and raise
JP Morgan analyst Brian Essex maintains Rapid7 (NASDAQ:RPD) with a Neutral and raises the price t
QMCO gained 44% after reporting strong Q1 earnings and guidance above estimates. Other gainers inclu
Barclays analyst Saket Kalia maintains Rapid7 (NASDAQ:RPD) with a Underweight and raises the pric
Rapid7 Inc (NASDAQ:RPD) on Monday posted upbeat earnings for the second quarter.
Rapid7 (RPD) posts upbeat Q2 earnings, beats analyst estimates. Raises guidance for EPS and sales. S
Stephens & Co. analyst Todd Weller maintains Rapid7 (NASDAQ:RPD) with a Equal-Weight and rai
Piper Sandler analyst Rob Owens maintains Rapid7 (NASDAQ:RPD) with a Neutral and raises the price
Baird analyst Shrenik Kothari maintains Rapid7 (NASDAQ:RPD) with a Neutral and raises the price t
Rapid7 NASDAQ: RPD reported second-quarter fiscal 2026 results that exceeded its guided metrics, whi
The headline numbers for Rapid7 (RPD) give insight into how the company performed in the quarter end
Rapid7, Inc. (RPD) Q2 2026 Earnings Call Transcript
Rapid7 (RPD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estima
Rapid7 (NASDAQ:RPD) raises FY2026 Adj EPS guidance from $1.52-$1.60 to $1.78-$1.83 vs $1.55 analyst
Rapid7 (NASDAQ:RPD) is looking for Q3 Adj EPS of $0.44-$0.47 vs $0.42 analyst estimate. sees sales o
Rapid7 (NASDAQ:RPD) reported quarterly earnings of $0.44 per share which beat the analyst consensus
Besides Wall Street's top-and-bottom-line estimates for Rapid7 (RPD), review projections for some of
BOSTON, July 28, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered
Tom Yeung here with your Sunday Digest . In the 2010s, getting acquired was the ultimate startup sta
Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin
Truist Securities analyst Miller Jump maintains Rapid7 (NASDAQ:RPD) with a Hold and raises the pr
Gainers Ceragon Networks (NASDAQ:CRNT) shares moved upwards by 12.3% to $2.38 during Tuesday's
Morgan Stanley analyst Meta Marshall downgrades Rapid7 (NASDAQ:RPD) from Equal-Weight to Underwei
US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 res
BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered
[url="]Niagen Bioscience, Inc.[/url] (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide aden
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global
Rapid7 (RPD) witnessed a jump in share price last session on above-average trading volume. The lates
CHICAGO--(BUSINESS WIRE)--Reveal, the provider of integrated AI-native platforms that span the eDisc
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered
Rapid7 is rated 'Buy' due to a promising management transition and AI-driven catalysts. The new CEO
BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1